Keymed Biosciences, Inc.

Keymed Biosciences is a Hong Kong-listed biopharmaceutical company focused on discovering and developing novel therapeutic antibodies. Its research includes antibodies, multispecific formats and antibody-drug conjugates, with a focus on immune-mediated diseases, chronic conditions and cancers. The company has capabilities extending from early discovery through clinical development and works toward manufacturing and commercialization of selected treatments. Its website provides corporate information and descriptions of key technology platforms. Antibody engineering and immune disease research remain central to its scientific positioning.